Which pharmaceutical company merger created the entity that developed the first mRNA-based COVID-19 vaccine approved for emergency use in the United States?

In the competitive world of pharmaceutical and life sciences, strategic mergers often reshape the industry landscape, combining intellectual property, research capabilities, and market access. This poll tests your knowledge about a significant brand merger that had profound implications for scientific research and drug development. Can you identify the correct merger that led to one of the largest R&D budgets in the pharmaceutical industry?

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Pfizer and BioNTech
Johnson & Johnson and Janssen
AstraZeneca and Oxford Biomedica
Moderna and Lonza